Beth M. Forster
Eli Lilly (United States)(US)
Publications by Year
Research Areas
Neuropeptides and Animal Physiology, Alzheimer's disease research and treatments, Pain Mechanisms and Treatments, Neuroscience and Neuropharmacology Research, Receptor Mechanisms and Signaling
Most-Cited Works
- → A Plaque-Specific Antibody Clears Existing β-amyloid Plaques in Alzheimer's Disease Mice(2012)443 cited
- → LY2456302 is a novel, potent, orally-bioavailable small molecule kappa-selective antagonist with activity in animal models predictive of efficacy in mood and addictive disorders(2013)150 cited
- → Broad spectrum efficacy with LY2969822, an oral prodrug of metabotropic glutamate 2/3 receptor agonist LY2934747, in rodent pain models(2017)22 cited
- → O4‐04‐02: Identification, characterization, and comparison of amino‐terminally truncated Aβ42 peptides in Alzheimer's disease brain tissue and in plasma from Alzheimer's patients receiving solanezumab immunotherapy treatment(2009)15 cited
- → A method to enhance the magnitude of tactile hypersensitivity following spinal nerve ligation in rats(2014)5 cited